Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2008 | 01-2008 | 10-2007 | 07-2007 | 04-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,709 | 1,073 | 366 | 507 | 4 |
| Inventories | N/A | 48 | N/A | N/A | N/A |
| TOTAL | $3,762 | $1,120 | $366 | $507 | $4 |
| Non-Current Assets | |||||
| Intangibles | 889 | 854 | 854 | 842 | 180 |
| TOTAL | $889 | $854 | $854 | $842 | $180 |
| Total Assets | $4,651 | $1,974 | $1,220 | $1,349 | $184 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 113 | 112 | 43 | 63 | 93 |
| Accrued Expenses | 35 | N/A | N/A | N/A | N/A |
| TOTAL | $1,014 | $463 | $394 | $415 | $445 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 505 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,014 | $463 | $394 | $415 | $445 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,772 | 2,648 | 2,639 | 2,634 | 2,634 |
| Common Shares | 33 | 32 | 32 | 32 | 28 |
| Retained earnings | -7,515 | -6,630 | -7,241 | -7,096 | -7,104 |
| Other shareholders' equity | 0 | -418 | -427 | -127 | -33 |
| TOTAL | $3,637 | $1,510 | $825 | $934 | $-261 |
| Total Liabilities And Equity | $4,651 | $1,974 | $1,220 | $1,349 | $184 |